Medicenna Therapeutics Corp's total assets for Q2 2026 were C$18.04M, a decrease of -20.77% from the previous quarter. TSE:MDNA total liabilities were C$7.80M for the fiscal quarter, a -4.06% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.